Nov. 23, 2025 /Mpelembe Media/ — A market insights report on the Alcohol Use Disorder (AUD) treatment market conducted by a life sciences market research firm, forecasts that the AUD market will grow rapidly at a Compound Annual Growth Rate (CAGR) of 13.6% by 2034, driven by rising disease prevalence and advancements in innovative therapies, including genetically-targeted treatments. The AUD market size was estimated at USD 1.1 billion in 2024 across seven key markets, with the United States accounting for the majority of the revenue. The report discusses current treatments and several emerging therapies in the pipeline from companies like Adial Pharmaceuticals and Beckley Psytech, which are expected to reshape the treatment landscape despite an ongoing significant treatment gap in patient care. Continue reading →